Senti Biosciences, Inc.

Dynamics Special Purpose Corp., trading under the ticker DYNS, is a blank check company that completed its initial public offering in 2021 and targets the life sciences and biotechnology sector. The SPAC, sponsored by Dynamics Sponsor LLC, announced a proposed business combination with Senti Biosciences, Inc., a gene circuit biotechnology company developing programmable cell and gene therapies. On December 10, 2021, DYNS filed a Form 10-Q/A — an amendment to a previously submitted quarterly report — with accession number 0001193125-21-353987, reflecting updated disclosures during the pre-merger period. The transaction ultimately closed in 2022. Sign up at SpacDesk for the full filing history, deal timeline, and analytics on DYNS and hundreds of other SPACs.